About Us
ipEssentia is a premier Intellectual Property (IP) firm with decades of deep domain expertise in the pharmaceutical and biotech industries. Our singular focus, specialized knowledge, and proven track record make us a trusted partner for companies seeking strategic IP solutions that drive innovation, growth, and competitive advantage.
Our Mission
To empower innovation by delivering cutting-edge Intellectual Property services that help businesses unlock value, strengthen competitiveness, and achieve sustainable success.
Our Vision
To be the trusted IP advisors to the pharmaceutical and biotech sectors, providing strategic IP planning for long-term growth and empowering innovation to reach its full potential.
Connect with us today!
Our Leadership
At the helm of ipEssentia is a leadership team with decades of global experience in translating complex technologies into actionable IP strategies. With unparalleled expertise across pharmaceutical R&D, IP-related regulatory frameworks, and business dynamics, we bring a rare blend of legal acumen and industry insight.
Led by two former Heads of IP from leading multinational pharmaceutical companies, our team adopts a proactive, practical, and commercially focused approach. By combining deep IP law expertise with strategic business perspective, we deliver clear, timely, innovative, and tailored solutions aligned with your business goals.
Dr. Poonam Raghuvanshi
- 32+ years of leadership in R&D and IP across the pharmaceutical industry
- Pharm and Doctorate in Pharmaceutical Chemistry
- Renowned for IP strategy development and cross-functional problem solving
Dr. Alka Mehta
- 28+ years of experience spanning R&D, IP, regulatory affairs, and pharmaceutical law
- Pharm, Ph.D. in Pharmaceutics, LLB, and Ph.D. in Pharmaceutical Law
- Specialist in IP risk mitigation, IP and litigation strategy, and competitive positioning
Our Team
Our multidisciplinary team of IP professionals, scientists, and legal experts brings experience from leading pharmaceutical companies, global law firms, and life sciences organizations. This ensures industry-centric, business-aligned solutions that combine scientific depth with legal precision.